149 completed, 36 unknown, 29 terminated, 12 withdrawn. 94 Phase 4, 46 Phase 1, 41 Phase 3, 33 Not applicable, 33 Phase 2.
Follow Metoprolol: new trials by email Literature Review of Metoprolol trials Research Report on Metoprolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation) Verapamil Hydrochloride, Metoprolol tartrate - Atrial Fibrillation (AF), Atrial Fibrillation With Rapid Ventricular Response | Phase 4 | Not yet recruiting | Muhammad Ali Javed | 120 | 2027-01-01 | 2026-08-03 |
| Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx) - Heart Failure With Reduced Ejection Fraction | Phase 4 | Recruiting | University of Michigan | 100 | 2026-12-01 | 2026-10-15 |
| Predicting Response and Exposure Changes in Cirrhosis for Effectiveness Five-Drug CYP Probe Cocktail - Liver Cirrhosis | Not applicable | Not yet recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 45 | 2026-11-01 | 2026-08-11 |
| BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy BHB-1893, Metoprolol - Cardiomyopathy, Hypertrophic Obstructive | Phase 3 | Recruiting | Braveheart Bio, Inc. | 210 | 2026-09-02 | 2026-11-10 |
| Dose-Response Interaction of Metoprolol and Sufentanil for Attenuating Hemodynamic Responses in Tracheal Intubation Metoprolol (MET), Sufentanil, Normal Saline (0.9% NaCl) - General Anesthesia; Tracheal Intubation | Phase 4 | Not yet recruiting | Fujian Provincial Hospital | 900 | 2026-06-22 | 2026-05-20 |
| SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation Verapamil 240 mg slow-release tablet, metoprolol 100 mg slow-release tablet - Atrial Fibrillation (AF) | Phase 4 | Not yet recruiting | Martini Hospital Groningen | 436 | 2026-06-01 | 2026-03-27 |
| Pharmacological Intervention to Prevent NOAF After TAVR Metoprolol succinate, Amiodarone - Atrial Fibrillation | Not applicable | Not yet recruiting | Shanghai East Hospital | 198 | 2026-04-07 | 2026-04-15 |
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | 60 | 2026-03-12 | 2026-05-06 |
| The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction mavacamten, Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol, diltiazem - Hypertrophic Cardiomyopathy (HCM) | Phase 4 | Enrolling by invitation | Second Affiliated Hospital, Zhejiang University, School of Medicine | 132 | 2026-03-01 | 2026-09-15 |
| Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF) Placebo (matching), Beta-blockers - Heart Failure, HFpEF | Phase 4 | Enrolling by invitation | Weill Medical College of Cornell University | 240 | 2026-02-02 | 2026-10-16 |
| Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD) | Phase 2 / Phase 3 | Enrolling by invitation | Gødstrup Hospital | 350 | 2025-12-15 | 2025-12-17 |
| Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries Atenolol Succinate Oral Tablet, Metoprolol Succinate Oral Tablet - Hypotension Drug-Induced | Phase 4 | Recruiting | Damanhour Teaching Hospital | 60 | 2025-12-01 | 2026-09-21 |
| Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator Metoprolol Succinate, Carvedilol - Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death | Phase 4 | Recruiting | University of Rochester | 2000 | 2025-08-17 | 2025-09-18 |
| Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA Saline (NaCl), Metoprolol Tartrate - Coronary Arterial Disease (CAD), Angina (Stable) | Phase 4 | Recruiting | VZW Cardiovascular Research Center Aalst | 46 | 2025-07-03 | 2025-07-14 |
| Early Beta Blocker Administration in STEMI Patients With SCAI B Status Metoprolol (MET), Plcacebo - ST Segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Post Myocardial Infarction | Not applicable | Recruiting | Tel-Aviv Sourasky Medical Center | 200 | 2025-05-21 | 2025-05-28 |
| To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants Retatrutide, Metoprolol - Healthy | Phase 1 | Completed | Eli Lilly and Company | 30 | 2025-02-03 | 2025-06-05 |
| An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates Amlitelimab, Midazolam, Caffeine - Dermatitis Atopic | Phase 1 | Completed | Sanofi | 23 | 2024-11-20 | 2026-04-23 |
| Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS) Metoprolol, Placebo - Non-Traumatic Subarachnoid Hemorrhage | Phase 4 | Active not recruiting | Madeleine Puissant | 20 | 2024-09-23 | 2026-10-19 |
| Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN) Metoprolol Injection, saline 0.9% - Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Terminated | Consorcio Centro de Investigación Biomédica en Red (CIBER) | 14 | 2024-07-10 | 2026-06-02 |
| CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes Metoprolol Succinate, Carvedilol - End-Stage Kidney Disease, End-Stage Renal Disease | Phase 3 | Recruiting | VA Office of Research and Development | 2540 | 2024-05-22 | 2026-10-13 |
Showing 20 of 249. Sign in to see all of them.
Hypertension (63) · Atrial Fibrillation (22) · Heart Failure (17) · Cardiovascular Diseases (11) · Coronary Artery Disease (10) · Diabetes Mellitus (9) · Diabetes Mellitus, Type 2 (9) · Heart Diseases (9) · Arrhythmias, Cardiac (5) · Cardiomyopathy, Hypertrophic (5) · Pulmonary Disease, Chronic Obstructive (5) · Acute Coronary Syndrome (4) · Burns (4) · Cardiomyopathies (4) · Dermatitis, Atopic (4)
AstraZeneca (8) · Saniona (7) · GlaxoSmithKline (5) · Boehringer Ingelheim (4) · Forest Laboratories (4) · Mayo Clinic (4) · Mylan Pharmaceuticals Inc (4) · The University of Texas Medical Branch, Galveston (4) · Weill Medical College of Cornell University (4) · China National Center for Cardiovascular Diseases (3) · Creighton University (3) · Eli Lilly and Company (3) · IPCA Laboratories Ltd. (3) · Kuopio University Hospital (3) · The George Institute (3)
United States (114) · China (25) · Germany (14) · Canada (10) · Denmark (9) · Sweden (7) · India (6) · Netherlands (6) · United Kingdom (6) · Australia (5) · Hungary (5) · Italy (5) · Norway (5) · Spain (5) · Finland (4)
David N Herndon, MD (4) · Shoujun Li, MD (3) · Ahmed M Shaat, MD (2) · Craig Anderson, PhD (2) · Dr. Manish Singhal, M.B.B.S (2) · Dr. P. Vijaya Lakshmi, Clinical Investigator (2) · Italo Biaggioni, MD (2) · James D Carlson, Pharm. D. (2) · Jie Wang, MD (2) · Julie A Johnson, PharmD (2) · Kim Krogsgaard, MD, DMSc (2)
PMID 32640944, PMID 17236889, PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 23303884, PMID 24694530, PMID 25503550, PMID 25589782, PMID 25657175, PMID 25712944, PMID 25823544, PMID 26746184, PMID 27165954, PMID 27178897, PMID 27480425, PMID 27847338, PMID 27919055, PMID 28115488, PMID 29523524, PMID 29925376, PMID 30753254, PMID 30890109, PMID 31085948, PMID 33598552, PMID 36526898, PMID 38018833, PMID 38353215, PMID 38747311, PMID 40541207, PMID 41855454, PMID 42848972, PMID 10342782, PMID 10851208, PMID 11386927, PMID 11581560, PMID 11799102, PMID 11927799, PMID 12119802, PMID 12435255, PMID 12923400, PMID 15738343, PMID 16235327, PMID 1627164, PMID 16271642, PMID 16271643, PMID 16391172, PMID 16476851, PMID 16533484
2005 (2), 2015 (2), 2018 (2), 2025 (2), 1UL1TR002373-01 (1), 2014 (1), 2016 (1), 2023 (1), K23AG030057 (1), K23GM110516 (1), K23HL146887 (1), K76AG064428 (1), N01HC95178 (1), N01HC95179 (1), N01HC95180 (1)